April 01, 1999; 52 (7) Article
The effect of estrogen replacement on early Parkinson’s disease
R. Saunders-Pullman, J. Gordon-Elliott, M. Parides, S. Fahn, H.R. Saunders, S. Bressman
First published April 1, 1999, DOI: https://doi.org/10.1212/WNL.52.7.1417
R. Saunders-Pullman
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
J. Gordon-Elliott
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
M. Parides
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
S. Fahn
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
H.R. Saunders
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
S. Bressman
From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
The effect of estrogen replacement on early Parkinson’s disease
R. Saunders-Pullman, J. Gordon-Elliott, M. Parides, S. Fahn, H.R. Saunders, S. Bressman
Neurology Apr 1999, 52 (7) 1417; DOI: 10.1212/WNL.52.7.1417
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 52 no. 7 1417
PubMed:
Print ISSN:
Online ISSN:
History:
- Received August 12, 1998
- Accepted in final form January 2, 1999
- First Published April 1, 1999.
Copyright & Usage:
© 1999
Author Disclosures
- R. Saunders-Pullman, MD, MPH,
- J. Gordon-Elliott, BA,
- M. Parides, PhD,
- S. Fahn, MD,
- H.R. Saunders, PhD and
- S. Bressman, MD
- R. Saunders-Pullman, MD, MPH,
- J. Gordon-Elliott, BA,
- M. Parides, PhD,
- S. Fahn, MD,
- H.R. Saunders, PhD and
- S. Bressman, MD
- From the Department of Neurology (Dr. Saunders-Pullman and Bressmanand J. Gordon-Elliott), Beth Israel Medical Center; Department of Neurology, Albert Einstein College of Medicine (Drs. Saunders-Pullman and Bressman), The Sergievsky Center, Columbia University (Dr. Saunders-Pullman); the Department of Biostatistics (M. Parides), Columbia University School of Public Health; and the Department of Neurology (Dr. Fahn), Columbia University College of Physicians and Surgeons, Columbia University, New York, NY.
- Address correspondence and reprint requests to Dr. Saunders-Pullman, Dept of Neurology, Suite 2Q, PACC, Beth Israel Medical Center, 10 Union Square East, New York, NY 10003.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scoresMaureen Leehey, Sheng Luo, Saloni Sharma et al.Neurology, September 29, 2017 -
Articles
Clinical trials aimed at detecting neuroprotection in Parkinson’s diseaseRobert A. Hauser, Theresa A. Zesiewicz et al.Neurology, May 22, 2006 -
Articles
Selegiline delays the onset of disability in de novo parkinsonian patientsS. Pålhagen, E. H. Heinonen, J. Hägglund et al.Neurology, August 01, 1998 -
Article
Putaminal serotonergic innervationMonitoring dyskinesia risk in Parkinson diseaseJee-Young Lee, Seongho Seo, Jae Sung Lee et al.Neurology, August 07, 2015